semaglutide 1 mg dose pen device Another Weight-Loss Trial Win for Weekly GLP-1 Drug behavior change Frequently Asked Questions | Ozempic®

Its renowned for enhancing the action of insulinthe hormone responsible for regulating blood sugar

The choice between GLP-1only and GLP-1/GIP dual agents depends on your metabolic phenotype, response pattern, and treatment goals

It is not authorized by Health Canada for human or veterinary use, and any introduction into humans or animals would fall outside lawful use

Obesity and metabolic conditions are among the most urgent health challenges worldwide , affecting over one-third of adults and contributing to diabetes, heart disease, and fatty liver disease

By following the science to understand more clearly the underlying links between the heart, kidneys, liver and pancreas, AstraZeneca is investing in a portfolio of medicines for organ protection by slowing or stopping disease progression, and ultimately paving the way towards regenerative therapies